The effect of erythromycin on motility of the duodenum, sphincter of Oddi, and gallbladder in the prairie dog

Howard S. Kaufman, Steven A. Ahrendt, Henry A. Pitt, Keith D. Lillemoe

Research output: Contribution to journalArticle

Abstract

Background. Interdigestive motility of the stomach, duodenum, sphincter of Oddi, and gallbladder is mediated through the migrating myoelectric complex and the action of motilin. Erythromycin, a motilin agonist, has recently been studied as a gastrointestinal and biliary prokinetic agent. We hypothesized that erythromycin would increase interdigestive duodenal and sphincter of Oddi motility in a dose-dependent manner. Methods. In 10 anesthetized prairie dogs we determined the motility responses of the duodenum, sphincter of Oddi, and gallbladder to erythromycin infusion during a three-log dosing regimen and correlated activity with serum concentrations of the drug. Results. Erythromycin administered at 0.01 and 0.1 mg/kg had no effect on duodenal or sphincter motility. At 1.0 and 10 mg/kg, duodenal motility index increased by 451% ± 114% and 1070% ± 480%, respectively, when compared with baseline values, (p <0.05). Sphincter of Oddi motility index increased by 122% ± 38% and 323% ± 99%, respectively, at these same doses of erythromycin (p <0.05). Gallbladder pressure did not change significantly during erythromycin infusion. Erythromycin serum concentration at 1.0 mg/kg was 1.0 ±0.7 μg/ml. Conclusions. These data suggest that erythromycin stimulates interdigestive motility of the duodenum and sphincter of Oddi in a dose-dependent manner at otherwise subtherapeutic concentrations of the drug.

Original languageEnglish (US)
Pages (from-to)543-548
Number of pages6
JournalSurgery
Volume114
Issue number3
StatePublished - 1993

Fingerprint

Sphincter of Oddi
Sciuridae
Erythromycin
Gallbladder
Duodenum
Motilin
Migrating Myoelectric Complexes
Serum
Pharmaceutical Preparations
Stomach
Pressure

ASJC Scopus subject areas

  • Surgery

Cite this

Kaufman, H. S., Ahrendt, S. A., Pitt, H. A., & Lillemoe, K. D. (1993). The effect of erythromycin on motility of the duodenum, sphincter of Oddi, and gallbladder in the prairie dog. Surgery, 114(3), 543-548.

The effect of erythromycin on motility of the duodenum, sphincter of Oddi, and gallbladder in the prairie dog. / Kaufman, Howard S.; Ahrendt, Steven A.; Pitt, Henry A.; Lillemoe, Keith D.

In: Surgery, Vol. 114, No. 3, 1993, p. 543-548.

Research output: Contribution to journalArticle

Kaufman, HS, Ahrendt, SA, Pitt, HA & Lillemoe, KD 1993, 'The effect of erythromycin on motility of the duodenum, sphincter of Oddi, and gallbladder in the prairie dog', Surgery, vol. 114, no. 3, pp. 543-548.
Kaufman, Howard S. ; Ahrendt, Steven A. ; Pitt, Henry A. ; Lillemoe, Keith D. / The effect of erythromycin on motility of the duodenum, sphincter of Oddi, and gallbladder in the prairie dog. In: Surgery. 1993 ; Vol. 114, No. 3. pp. 543-548.
@article{038f32b828fd4ef7aadde7dae97280d3,
title = "The effect of erythromycin on motility of the duodenum, sphincter of Oddi, and gallbladder in the prairie dog",
abstract = "Background. Interdigestive motility of the stomach, duodenum, sphincter of Oddi, and gallbladder is mediated through the migrating myoelectric complex and the action of motilin. Erythromycin, a motilin agonist, has recently been studied as a gastrointestinal and biliary prokinetic agent. We hypothesized that erythromycin would increase interdigestive duodenal and sphincter of Oddi motility in a dose-dependent manner. Methods. In 10 anesthetized prairie dogs we determined the motility responses of the duodenum, sphincter of Oddi, and gallbladder to erythromycin infusion during a three-log dosing regimen and correlated activity with serum concentrations of the drug. Results. Erythromycin administered at 0.01 and 0.1 mg/kg had no effect on duodenal or sphincter motility. At 1.0 and 10 mg/kg, duodenal motility index increased by 451{\%} ± 114{\%} and 1070{\%} ± 480{\%}, respectively, when compared with baseline values, (p <0.05). Sphincter of Oddi motility index increased by 122{\%} ± 38{\%} and 323{\%} ± 99{\%}, respectively, at these same doses of erythromycin (p <0.05). Gallbladder pressure did not change significantly during erythromycin infusion. Erythromycin serum concentration at 1.0 mg/kg was 1.0 ±0.7 μg/ml. Conclusions. These data suggest that erythromycin stimulates interdigestive motility of the duodenum and sphincter of Oddi in a dose-dependent manner at otherwise subtherapeutic concentrations of the drug.",
author = "Kaufman, {Howard S.} and Ahrendt, {Steven A.} and Pitt, {Henry A.} and Lillemoe, {Keith D.}",
year = "1993",
language = "English (US)",
volume = "114",
pages = "543--548",
journal = "Surgery",
issn = "0039-6060",
publisher = "Mosby Inc.",
number = "3",

}

TY - JOUR

T1 - The effect of erythromycin on motility of the duodenum, sphincter of Oddi, and gallbladder in the prairie dog

AU - Kaufman, Howard S.

AU - Ahrendt, Steven A.

AU - Pitt, Henry A.

AU - Lillemoe, Keith D.

PY - 1993

Y1 - 1993

N2 - Background. Interdigestive motility of the stomach, duodenum, sphincter of Oddi, and gallbladder is mediated through the migrating myoelectric complex and the action of motilin. Erythromycin, a motilin agonist, has recently been studied as a gastrointestinal and biliary prokinetic agent. We hypothesized that erythromycin would increase interdigestive duodenal and sphincter of Oddi motility in a dose-dependent manner. Methods. In 10 anesthetized prairie dogs we determined the motility responses of the duodenum, sphincter of Oddi, and gallbladder to erythromycin infusion during a three-log dosing regimen and correlated activity with serum concentrations of the drug. Results. Erythromycin administered at 0.01 and 0.1 mg/kg had no effect on duodenal or sphincter motility. At 1.0 and 10 mg/kg, duodenal motility index increased by 451% ± 114% and 1070% ± 480%, respectively, when compared with baseline values, (p <0.05). Sphincter of Oddi motility index increased by 122% ± 38% and 323% ± 99%, respectively, at these same doses of erythromycin (p <0.05). Gallbladder pressure did not change significantly during erythromycin infusion. Erythromycin serum concentration at 1.0 mg/kg was 1.0 ±0.7 μg/ml. Conclusions. These data suggest that erythromycin stimulates interdigestive motility of the duodenum and sphincter of Oddi in a dose-dependent manner at otherwise subtherapeutic concentrations of the drug.

AB - Background. Interdigestive motility of the stomach, duodenum, sphincter of Oddi, and gallbladder is mediated through the migrating myoelectric complex and the action of motilin. Erythromycin, a motilin agonist, has recently been studied as a gastrointestinal and biliary prokinetic agent. We hypothesized that erythromycin would increase interdigestive duodenal and sphincter of Oddi motility in a dose-dependent manner. Methods. In 10 anesthetized prairie dogs we determined the motility responses of the duodenum, sphincter of Oddi, and gallbladder to erythromycin infusion during a three-log dosing regimen and correlated activity with serum concentrations of the drug. Results. Erythromycin administered at 0.01 and 0.1 mg/kg had no effect on duodenal or sphincter motility. At 1.0 and 10 mg/kg, duodenal motility index increased by 451% ± 114% and 1070% ± 480%, respectively, when compared with baseline values, (p <0.05). Sphincter of Oddi motility index increased by 122% ± 38% and 323% ± 99%, respectively, at these same doses of erythromycin (p <0.05). Gallbladder pressure did not change significantly during erythromycin infusion. Erythromycin serum concentration at 1.0 mg/kg was 1.0 ±0.7 μg/ml. Conclusions. These data suggest that erythromycin stimulates interdigestive motility of the duodenum and sphincter of Oddi in a dose-dependent manner at otherwise subtherapeutic concentrations of the drug.

UR - http://www.scopus.com/inward/record.url?scp=0027226065&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027226065&partnerID=8YFLogxK

M3 - Article

C2 - 8367809

AN - SCOPUS:0027226065

VL - 114

SP - 543

EP - 548

JO - Surgery

JF - Surgery

SN - 0039-6060

IS - 3

ER -